References

Citations

1. American Academy of Pediatrics (2009). Respiratory syncytial virus. In LK Pickering et al., eds., Red Book: 2009 Report of the Committee on Infectious Diseases, 28th ed., pp. 560–569. Elk Grove Village, IL: American Academy of Pediatrics.

2. Schwarze J, et al. (2004). Latency and persistence of respiratory syncytial virus despite T cell immunity. American Journal of Respiratory and Critical Care Medicine, 169(7): 801–805.

3. Hall CB, Walsh EE (2009). Respiratory syncytial virus. In RD Feigin et al., eds., Feigin and Cherry's Textbook of Pediatric Infectious Diseases, 6th ed., vol. 2, pp. 2462–2487. Philadelphia: Saunders Elsevier.

4. Horga MA, Moscona A (2006). Respiratory syncytial virus. In FD Burg et al., eds., Current Pediatric Therapy, 18th ed., pp. 793–797. Philadelphia: Saunders Elsevier.

Other Works Consulted

• Committee on Infectious Diseases, American Academy of Pediatrics (2009). Modified recommendations for use of palivizumab for prevention of respiratory syncytial virus infections. Pediatrics, 124(6): 1694–1701.

• Hall CB (2010). Respiratory syncytial virus. In GL Mandell et al., eds., Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases, 7th ed., vol. 2, pp. 2207–2221. Philadelphia: Churchill Livingstone Elsevier.

• Hayden FG and Ison MG (2006). Respiratory viral infections. In DC Dale, DD Federman, eds., ACP Medicine, section 7, chap. 25. New York: WebMD.

• Ventre K, Randolph A (2007). Ribavirin for respiratory syncytial virus infection of the lower respiratory tract in infants and young children. Cochrane Database of Systematic Reviews (1).

• Walsh EE (2008). Respiratory syncytial virus. In L Goldman, D Ausiello, eds., Cecil Medicine, 23rd ed., chap. 385, pp. 2462–2463. Philadelphia: Saunders Elsevier.